Linda is the managing director of the Nussbaum Law Group, PC. She is nationally recognized for her representation of class and individual plaintiffs in antitrust, RICO, CEA, and pharmaceutical litigation. She has served as sole or co-lead counsel in many significant class actions which have resulted in substantial recoveries, many in the realm of hundreds of millions of dollars. Linda is currently lead counsel in:
- In re Payment Card Interchange Fee and Merchant Discount Antitrust Litigation (E.D.N.Y.)
- In re Aluminum Warehousing Antitrust Litigation (S.D.N.Y.)
- In re Zinc Antitrust Litigation (S.D.N.Y.)
- In re Actos Direct Purchaser Antitrust Litigation (S.D.N.Y.)
- Washington County Health Care Authority Inc. v. Baxter International Inc., et al. (N.D.Ill.)
Linda is also presently serving as one of the class allocation counsel in In re Foreign Exchange Benchmark Antitrust Litigation (S.D.N.Y.), and serves on the Plaintiffs’ Steering Committee in In re Generic Pharmaceuticals Pricing Antitrust Litigation (E.D. Pa.) and In re Liquid Aluminum Sulfate Antitrust Litigation (D.N.J.). She served as co-lead counsel at her prior law firm and maintains a significant role in In re London Silver Fixing, Ltd. Antitrust Litigation, (S.D.N.Y.).
She also represents large corporate clients pursuing direct actions in In re Packaged Seafood Products Antitrust Litigation, (S.D. Cal.), In re American Express Anti-Steering Rules Antitrust Litig., (E.D.N.Y.), and in an earlier phase of In re Payment Card Interchange Fee and Merchant Discount Antitrust Litigation (E.D.N.Y.).
Linda was selected “Litigator of the Week” by the AmLaw Litigation Daily on April 2, 2010 for her lead trial role in Kaiser Foundation Health Plan, Inc. and Kaiser Foundation Hospitals v. Pfizer, where, after a six-week trial, a jury returned a RICO verdict for her clients. She was a finalist for Public Justice Foundation’s 2011 Trial Lawyer of the Year award. She has lectured extensively about antitrust and class action law, regularly moderating and participating in panel discussions at the annual American Antitrust Institute Private Enforcement Conference, the annual American Bar Association, Section of Antitrust Law Spring Meeting, and other American Bar Association panels. She has also has authored numerous publications.
Linda’s successful prosecution of complex litigation has been recognized and commended by judges in matters in which she has served as lead counsel.
Chief Judge Hogan of the District of Columbia commented in In re Lorazepam & Clorazepate Antitrust Litigation, No. 99-cv-00276 (D.D.C.):
“Obviously, the skill of the attorneys, and I’m not going to spend the time reviewing it, I’m familiar with counsel, and they, as I said, are among the best antitrust litigators in the country.”
From Judge Faith S. Hochberg of the District of New Jersey:
“[W]e sitting here don’t get to see such fine lawyering, and it’s really wonderful for me both to have tough issues and smart lawyers. On behalf of the entire federal judiciary I want to thank you for the kind of lawyering we wish everybody would do.”
Following the trial in In re Neurontin Marketing and Sales Practices Litigation, No. 04cv10981 (D.Mass.), Judge Patti Saris commented that:
“[this was]a fabulous trial[.] [I]t’s the kind of thing that you become a judge to sit on.”
Linda received her B.A. (magna cum laude) from Brooklyn College, her J.D. (with honors) from the National Law Center, George Washington University Law School, and her LLM in taxation from New York University Law School.